Please provide your email address to receive an email when new articles are posted on . “Cryoconvergent” hybrid ablation for atrial fibrillation may significantly reduce risk for recurrent AF and AF ...

AtriCure's investors will have to wait a bit longer to find out if and when FDA will approve the company's Convergent hybrid ablation procedure for atrial fibrillation. There has been significant ...

ZANESVILLE − Genesis HealthCare System’s cardiothoracic and electrophysiology surgery teams recently performed their first convergent procedure. It can reduce the risk of stroke and eliminate blood ...

DENVER (CBS4) - Almost three million people in the U.S. suffer from atrial fibrillation, a type of irregular heartbeat. It can cause shortness of breath and is a leading cause of stroke. CBS4 Health ...

Parkridge Medical Center became the first hospital in Chattanooga to offer the Convergent Procedure as a treatment for persistent atrial fibrillation, the most prevalent heart rhythm disorder and a ...

In patients with atrial fibrillation, the upper chambers of the heart beat out of rhythm. With difficult to treat cases, patients chose between two solutions: scarring the heart from inside with an ...

It’s a condition that can make your heart race and put you at risk for stroke. But for some patients, medication can’t control atrial fibrillation. See how two top surgeons are teaming up to offer a ...

Doctors at Genesys Heart Institute in Grand Blanc Township are performing a new procedure to treat patients with persistent atrial fibrillation. GRAND BLANC TWP, MI – Doctors at Genesys are performing ...

Results presented virtually via Heart Rhythm 365 Platform; study met primary effectiveness endpoint of superiority in favor of the hybrid Convergent procedure MASON, Ohio--(BUSINESS WIRE)-- AtriCure, ...

nContact Surgical (Morrisville, North Carolina) said it has received the first investigational device exemption (IDE) from the FDA to evaluate the safety and efficacy of a combined surgical and ...

MASON, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced the results ...